Hydrocortisone acetate is a clinically-commonly-used glucocorticoid. It exerts multiple pharmacological effects including anti-inflammatory, anti-allergic, immunosuppressive and anti-shock activities. Available in a wide range of dosage forms such as cream, injection and tablet, it is widely prescribed in multiple departments including dermatology, internal medicine and emergency department for the treatment of various conditions such as allergic dermatitis, eczema, autoimmune diseases and severe infections. Like all medicines, hydrocortisone acetate is not absolutely safe. Various adverse reactions may occur under standardized treatment or following long-term and over-dosage use. Understanding the types, triggers and management of its adverse reactions is critical for safe medication and risk avoidance. This article systematically reviews its adverse-reaction profile and relevant medication precautions.
I. Mechanism of Action and Triggers of Adverse Reactions
Hydrocortisone acetate produces therapeutic effects mainly by inhibiting inflammatory responses, lowering the activity of immune cells and reducing the release of allergic mediators such as histamine. As a hormone-based agent, however, it interferes with the body's normal endocrine, metabolic and immune homeostasis, which constitutes the core cause of its adverse reactions.
II. Common Mild Adverse Reactions
Adverse reactions of topical preparations are predominantly local skin manifestations. Long-term application of hydrocortisone acetate cream may lead to local skin thinning, dryness and desquamation, telangiectasia, and some patients may develop hyperpigmentation or hypopigmentation as well as hypertrichosis. A small number of users may experience mild local stinging, pruritus or burning sensation, which generally does not preclude continued administration and tends to subside gradually after adaptation.
III. Infrequent Severe Adverse Reactions
The first category is endocrine and metabolic disturbances. Prolonged medication suppresses adrenocortical function, resulting in adrenal atrophy and insufficient hormone secretion, with symptoms such as fatigue, hypotension and abnormal weight change. It may also disturb carbohydrate and lipid metabolism, triggering hyperglycaemia, central obesity and dyslipidaemia. Long-term use in children may impair growth and development and lead to growth retardation.
In addition, digestive-system injuries may occur. Long-term administration irritates the gastric mucosa, damages its protective barrier and induces gastritis and gastric ulcer; severe cases may present with gastric haemorrhage, abdominal pain and melaena. A very small proportion of patients may develop osteoporosis, joint pain and even avascular necrosis of the femoral head, mostly seen in patients receiving long-term high-dose intravenous therapy.
IV. Management of Adverse Reactions and Medication Principles
For all types of adverse reactions associated with hydrocortisone acetate, the core principle is prevention-oriented management with timely intervention. Patients must take the medicine strictly as prescribed, and are prohibited from adjusting the dosage or extending the treatment duration on their own. Topical preparations shall not be applied over a large area or used continuously for a long period, while oral and injectable routes require strict control of treatment courses.
Extra caution shall be exercised for special populations. Children, the elderly, pregnant and lactating women, patients with hepatic-renal diseases, diabetes or osteoporosis shall receive reduced doses under medical supervision. Physical indicators should be monitored regularly during treatment to mitigate medication risks.
V. Conclusion
Hydrocortisone acetate delivers definite therapeutic efficacy and broad clinical applicability, yet carries well-documented risks of adverse reactions whose severity varies between individuals and administration routes. Short-term standardized treatment is relatively safe with no excessive concern required, whereas irregular, long-term and high-dose use may cause multi-system damage involving the endocrine, immune, digestive and skeletal systems. Therefore, both clinical and self-administration should strictly follow medical advice, standardize medication procedures, closely monitor bodily responses and implement risk-control measures, so as to maximize therapeutic benefits while minimizing harm induced by adverse reactions.
